Epidemiology of Hepatitis E in England and Wales: A 10-Year Retrospective Surveillance Study, 2008-2017.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
31 07 2019
Historique:
received: 17 03 2019
accepted: 23 04 2019
pubmed: 21 5 2019
medline: 22 5 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

Indigenous, foodborne transmission of hepatitis E virus genotype 3 (HEV G3) has become recognized as an emerging problem in industrialized countries. Although mostly asymptomatic, HEV G3 infection has a range of outcomes, including mild illness, severe acute hepatitis, and, of particular concern, chronic progressive hepatitis in immunocompromised patients. Public Health England has monitored cases of acute HEV infection in England and Wales since 2003. Between 2010 and 2017, enhanced surveillance using 2 linked laboratory databases and questionnaires on clinical features and risk factors was conducted. There was a year-on-year increase in the number of infections from 2008 (183) through 2016 (1243). Then, in 2017, the number of infections declined (to 912). As reported previously, HEV G3 group 2 (also known as "G3 abcdhij") is the predominant cause of acute infections, and older men are most at risk. Consumption of pork and pork products was significantly higher among patients than in the general population, but other previously reported associations, such as consumption of shellfish, were not observed. Ongoing surveillance is required to monitor future trends and changes in the epidemiology of the virus. The changing methods of animal husbandry and processing and distribution of animal products needs to be further investigated.

Identifiants

pubmed: 31107958
pii: 5479512
doi: 10.1093/infdis/jiz207
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

802-810

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Clarissa Oeser (C)

Emerging Infections and Zoonoses, Public Health England, London.
National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.

Aisling Vaughan (A)

Emerging Infections and Zoonoses, Public Health England, London.
National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, United Kingdom.

Bengü Said (B)

Emerging Infections and Zoonoses, Public Health England, London.

Samreen Ijaz (S)

Blood Borne Viruses Unit, Public Health England, London.

Richard Tedder (R)

Blood Borne Viruses Unit, Public Health England, London.

Becky Haywood (B)

Blood Borne Viruses Unit, Public Health England, London.

Fiona Warburton (F)

Statistics, Modelling, and Economics Department, Public Health England, London.

Andre Charlett (A)

Statistics, Modelling, and Economics Department, Public Health England, London.

Richard Elson (R)

Gastrointestinal Infections, National Infection Service, Public Health England, London.

Dilys Morgan (D)

Emerging Infections and Zoonoses, Public Health England, London.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH